Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1h-1,2,4-triazole-5-carboxamide, 3-(phenylmethyl)-n-((3s)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl)-
2. 3-benzyl-n-((3s)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl)-1h-1,2,4-triazole-5-carboxamide
3. Gsk2982772
1. Gsk2982772
2. 1622848-92-3
3. Gsk-2982772
4. T5w3m0vo9b
5. (s)-3-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1h-1,2,4-triazole-5-carboxamide
6. Chembl4071864
7. 1622848-92-3 (free Base)
8. Gsk 2982772
9. 5-benzyl-n-[(3s)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1h-1,2,4-triazole-3-carboxamide
10. (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b]-[1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide
11. (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4h-1,2,4-triazole-3-carboxamide
12. 1h-1,2,4-triazole-5-carboxamide, 3-(phenylmethyl)-n-((3s)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl)-
13. 3-benzyl-n-[(3s)-5-methyl-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-1h-1,2,4-triazole-5-carboxamide
14. Unii-t5w3m0vo9b
15. Gtpl9554
16. Schembl15956219
17. Schembl21678862
18. Amy16731
19. Ex-a2558
20. Bdbm50233225
21. Mfcd30828708
22. S8484
23. Akos037643747
24. Ccg-268376
25. Compound 5 [pmid: 28151659]
26. Cs-6899
27. Ac-29894
28. As-35128
29. Bg166667
30. Hy-101760
31. J3.650.802g
32. A912055
33. 7mj
| Molecular Weight | 377.4 g/mol |
|---|---|
| Molecular Formula | C20H19N5O3 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 377.14878949 g/mol |
| Monoisotopic Mass | 377.14878949 g/mol |
| Topological Polar Surface Area | 100 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 568 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
75
PharmaCompass offers a list of GSK2982772 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right GSK2982772 manufacturer or GSK2982772 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred GSK2982772 manufacturer or GSK2982772 supplier.
PharmaCompass also assists you with knowing the GSK2982772 API Price utilized in the formulation of products. GSK2982772 API Price is not always fixed or binding as the GSK2982772 Price is obtained through a variety of data sources. The GSK2982772 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GSK2982772 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GSK2982772, including repackagers and relabelers. The FDA regulates GSK2982772 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GSK2982772 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GSK2982772 supplier is an individual or a company that provides GSK2982772 active pharmaceutical ingredient (API) or GSK2982772 finished formulations upon request. The GSK2982772 suppliers may include GSK2982772 API manufacturers, exporters, distributors and traders.
GSK2982772 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GSK2982772 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GSK2982772 GMP manufacturer or GSK2982772 GMP API supplier for your needs.
A GSK2982772 CoA (Certificate of Analysis) is a formal document that attests to GSK2982772's compliance with GSK2982772 specifications and serves as a tool for batch-level quality control.
GSK2982772 CoA mostly includes findings from lab analyses of a specific batch. For each GSK2982772 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GSK2982772 may be tested according to a variety of international standards, such as European Pharmacopoeia (GSK2982772 EP), GSK2982772 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GSK2982772 USP).
